Meaurement of advanced glycation end products may change NASH managment.

The article reflects the opinion of the author on the significance of the measurement of advanced glycation end products (AGEs) in the changes on the management of non-alcoholic steatohepatitis. The author stressed that the discovery of nonenzygmatic AGEs and its receptors paved the way to new researches in medicine . Meanwhile, the author suggests that measurement of circulating AGEs can be a beneficial tool for discriminating patients with NASH.